- Psychemedics Corporation (PMD, Financial) awarded "Most Innovative Drug Testing Company of the Year" in 2025.
- Launch of Enhanced Quartile Reporting advances analytics in drug testing.
- Strong technology serving Fortune 500 companies, law enforcement, and high-risk sectors.
Psychemedics Corporation (PMD), the world's leading provider of hair drug testing, has been named "Most Innovative Drug Testing Company of the Year" by Acquisition International Magazine in the 2025 Global Excellence Awards. This accolade highlights Psychemedics' ongoing leadership in advancing drug detection technologies, particularly its recent introduction of Enhanced Quartile Reporting.
The Enhanced Quartile Reporting system is a significant breakthrough in drug testing analytics, offering deeper insights into the severity of drug use and behavioral risk patterns by categorizing positive results into population-based quartiles. This tool provides an additional layer of interpretive value, helping organizations, especially in high-risk sectors such as transportation, oil and gas, and insurance, to make more informed safety and risk management decisions.
CEO Brian Hullinger stated, "Being recognized as the most innovative drug testing company of the year is a powerful validation of our team’s commitment to science, research, and client success. Innovation is at the core of everything we do, whether advancing the reliability of our testing or providing actionable insights that help our clients make better hiring and risk decisions."
Psychemedics' hair testing technology is renowned for its unmatched detection sensitivity, tamper resistance, and extended detection window, making it the preferred choice for Fortune 500 companies, law enforcement, schools, and insurers. The company's continued dedication to scientific advancement ensures its leading position in the drug testing industry.
